New study aims to perfect anesthesia dosing for different ages
NCT ID NCT07665151
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study will enroll 108 adults having surgery with a laryngeal mask airway. Researchers want to find the dose of tegileridine (combined with propofol) that prevents movement, coughing, and other reactions in 90% of patients. They will compare younger (18-65) and older (65+) groups to see if age affects the needed dose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tegileridine combined with propofol
What this could lead to
If successful, this could help anesthesiologists choose safer, more effective doses of tegileridine for patients of different ages during surgery.
What could go wrong
This is a small, early-phase dose-finding study, not a large trial. Results may not apply to all patients or surgeries, and side effects are still being explored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELECTIVE SURGERY REQUIRING LARYNGEAL MASK AIRWAY GENERAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianmen First People's Hospital, Affiliated Hospital of Wuhan University of Science and Technology
Tianmen, Hubei, 431700, China
Contact Phone: •••-•••-•••• Email: •••••@•••••